Transcatheter Embolization and Occlusion Devices Market by Product - Global Industry Analysis and Forecast to 2023

2018-05-30 / 3800.00 / Pharma & Healthcare / 90 Pages

Description

Industry Outlook and Trend Analysis

The Transcatheter Embolization and Occlusion Devices Market was worth USD 2.34 billion in 2014 and is expected to reach approximately USD 5.29 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.50% during the forecast period. The market is observing significant development in the course of the most recent decade. The change in perspective from clipping to coiling has invigorated the interest for transcatheter embolization devices. Rising demand of embolization strategies in the treatment of cancer is basically boosting the TEO market development. Minimally invasive surgery is another main consideration decidedly affecting the worldwide business. Commercially accessible embolization products, for example, fluid embolic and embolization particles bolster minimally invasive surgeries. Minimally invasive surgeries lessen recuperating time and surgical injuries.

Product Outlook and Trend Analysis

Coils and non-coils are the two kinds of embolization gadgets financially accessible. Coiling being one of the oldest methods is generally embraced by healthcare professionals comprehensively. In addition, accessibility of a wide scope of coils in different shapes and sizes additionally makes the system more positive for various cases. Pushable coils represented the biggest share of around 56% of every 2014 inferable from high awareness with respect to the product. Nonetheless, disadvantages related with pushable coils , for example, the likelihood of being trapped in sharp curves of the veins, trouble in repositioning once sent, and plausibility of getting stuck in catheters are seen to hinder its selection.

Regional Outlook and Trend Analysis

North America and Europe together represented the largest share of the overall industry of around 58% in 2014. The existence of well-defined regulatory framework, propelled social insurance framework, and experienced medicinal services experts to play out the strategies are a portion of the elements encountered to fuel interest for TEO in these areas. Asia Pacific is foreseen to develop at the speediest CAGR amid the estimate time frame.

Competitive Insights

The leading players in the market are St. Jude Medical, DePuy Synthes Companies, Medtronic, Cook Group, Stryker Corporation, Terumo Corporation, Cordis Corporation, Sirtex Medical and Boston Scientific. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Transcatheter Embolization and Occlusion Devices Market is segmented as follows-

By Product:


Coils


Detachable Coils
Pushable Coils


Non-Coils

Embolization Particles
Liquid Embolics
Flow Diverting Devices
Other Embolization and Occlusion Devices
Accessories




By Region


North America



U.S
Canada
Mexico



Europe



Germany
France
UK
Italy
Spain
Rest of Europe



Asia-Pacific



Japan
China
Australia
India
South Korea
Rest of Asia Pacific



Rest of the World



Brazil
South Africa
Saudi Arabia
United Arab Emirates
Others


Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2023`
What will be the industry market growth from 2015 to 2023`
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast`
What are the major segments leading the market growth and why`
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition`

Table of Content

Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Rising Demand in End-User Industries
3.2.2. Restraints
3.2.2.1. Volatile Raw Material Prices
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Transcatheter Embolization and Occlusion Devices Market, By Product
4.1. Introduction
4.2. Global Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share by Product (2014-2017)
4.2.1. Global Transcatheter Embolization and Occlusion Devices Sales and Sales Share by Product (2014-2017)
4.2.2. Global Transcatheter Embolization and Occlusion Devices Revenue and Revenue Share by Product (2014-2017)
4.3. Transcatheter Embolization and Occlusion Devices Market Assessment and Forecast, By Product, 2014-2023
4.4. Coil
4.4.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
4.4.2. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.4.3. Pushable Coils
4.4.3.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.4.4. Detachable Coils
4.4.4.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.5. Non Coil
4.5.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
4.5.2. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.5.3. Flow Diverting Devices
4.5.3.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.5.4. Embolization Particles
4.5.4.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.5.5. Liquid Embolics
4.5.5.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.5.6. Other Embolization and Occlusion Devices
4.5.6.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.5.7. Accessories
4.5.7.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
5. Transcatheter Embolization and Occlusion Devices Market , By Region
5.1. Introduction
5.2. Transcatheter Embolization and Occlusion Devices Market Assessment and Forecast, By Region, 2014-2023($Million)
5.3. Global Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share by Regions
5.3.1. Global Transcatheter Embolization and Occlusion Devices Sales by Regions (2014-2017)
5.3.2. Global Transcatheter Embolization and Occlusion Devices Revenue by Regions (2014-2017)
5.4. North America
5.4.1. North America Transcatheter Embolization and Occlusion Devices Sales and Growth Rate (2014-2017)
5.4.2. Market Assessment and Forecast, By Country, 2014-2023($Million)
5.4.3. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.4.4. U.S.
5.4.4.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.4.5. Canada
5.4.5.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.4.6. Mexico
5.4.6.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.5. Europe
5.5.1. Europe Transcatheter Embolization and Occlusion Devices Sales and Growth Rate (2014-2017)
5.5.2. Market Assessment and Forecast, By Country, 2014-2023($Million)
5.5.3. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.5.4. Germany
5.5.4.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.5.5. France
5.5.5.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.5.6. UK
5.5.6.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.5.7. Italy
5.5.7.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.5.8. Spain
5.5.8.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.5.9. Rest of Europe
5.5.9.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.6. Asia-Pacific
5.6.1. Asia-Pacific Transcatheter Embolization and Occlusion Devices Sales and Growth Rate (2014-2017)
5.6.2. Market Assessment and Forecast, By Country, 2014-2023($Million)
5.6.3. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.6.4. Japan
5.6.4.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.6.5. China
5.6.5.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.6.6. Australia
5.6.6.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.6.7. India
5.6.7.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.6.8. South Korea
5.6.8.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.6.9. Rest of Asia-Pacific
5.6.9.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.7. Rest of the World
5.7.1. Rest of the World Transcatheter Embolization and Occlusion Devices Sales and Growth Rate (2014-2017)
5.7.2. Market Assessment and Forecast, By Country, 2014-2023($Million)
5.7.3. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.7.4. Brazil
5.7.4.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.7.5. Turkey
5.7.5.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.7.6. Saudi Arabia
5.7.6.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.7.7. South Africa
5.7.7.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.7.8. United Arab Emirates
5.7.8.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
5.7.9. Others
5.7.9.1. Market Assessment and Forecast, By Product, 2014-2023($Million)
6. Company Profiles
6.1. Boston Scientific Corporation
6.1.1. Business Overview
6.1.2. Product Portfolio
6.1.3. Strategic Developments
6.1.4. Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share
6.2. Terumo Corporation
6.2.1. Business Overview
6.2.2. Product Portfolio
6.2.3. Strategic Developments
6.2.4. Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share
6.3. Medtronic, Inc.
6.3.1. Business Overview
6.3.2. Product Portfolio
6.3.3. Strategic Developments
6.3.4. Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share
6.4. Merit Medical System
6.4.1. Business Overview
6.4.2. Product Portfolio
6.4.3. Strategic Developments
6.4.4. Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share
6.5. DePuy Synthes
6.5.1. Business Overview
6.5.2. Product Portfolio
6.5.3. Strategic Developments
6.5.4. Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share
6.6. Stryker Corporation
6.6.1. Business Overview
6.6.2. Product Portfolio
6.6.3. Strategic Developments
6.6.4. Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share
6.7. Cordis Corporation
6.7.1. Business Overview
6.7.2. Product Portfolio
6.7.3. Strategic Developments
6.7.4. Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share
6.8. St. Jude Medical
6.8.1. Business Overview
6.8.2. Product Portfolio
6.8.3. Strategic Developments
6.8.4. Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share
6.9. Pfizer, Inc.
6.9.1. Business Overview
6.9.2. Product Portfolio
6.9.3. Strategic Developments
6.9.4. Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share
6.10. Sirtex medical
6.10.1. Business Overview
6.10.2. Product Portfolio
6.10.3. Strategic Developments
6.10.4. Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share
7. Global Transcatheter Embolization and Occlusion Devices Market Competition, by Manufacturer
7.1. Global Transcatheter Embolization and Occlusion Devices Sales and Market Share by Manufacturer (2016-2017)
7.2. Global Transcatheter Embolization and Occlusion Devices Revenue and Market Share by Manufacturer (2016-2017)
7.3. Top 5 Transcatheter Embolization and Occlusion Devices Manufacturer Market Share
7.4. Market Competition Trend
List of Tables and Figures
*You can glance through the list of Tables and Figures when you view the sample copy of Transcatheter Embolization and Occlusion Devices Market.


Table of Figures

*You can glance through the list of Tables and Figures when you view the sample copy of Biomass Energy Market.

Request Sample

* mark fields are compulsory